Dasatinib
Generic name: Dasatinib
Brand names: Sprycel
Dosage form: oral tablet (100 mg; 140 mg; 20 mg; 50 mg; 70 mg; 80 mg)
Drug class:
BCR-ABL tyrosine kinase inhibitors
Usage of Dasatinib
Dasatinib is a cancer medicine that slows the growth and spread of cancer cells in the body.
Dasatinib is used in adults and children to treat a type of blood cancer called Philadelphia chromosome-positive chronic myelogenous leukemia (CML).
Dasatinib is also used to treat Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) in adults and children.
Dasatinib side effects
Get emergency medical help if you have signs of an allergic Reaction to dasatinib (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning in your eyes, skin pain, red or purple skin rash with blistering and peeling).
Call your doctor right away if you have any symptoms of pulmonary arterial hypertension (PAH), such as:
Also call your doctor at once if you have:
Dasatinib may affect growth in children. Tell your doctor if your child is not growing at a normal rate while using this medicine.
Common dasatinib side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Dasatinib
Some people using dasatinib have developed a rare but serious condition called pulmonary arterial hypertension (PAH). PAH occurs when blood pressure increases inside the arteries in your lungs. This makes it harder for your heart to pump blood through the lungs, which also weakens muscles in the heart. PAH may be irreversible if not promptly treated, and this condition can be fatal. Talk to your doctor about your specific risk of developing PAH.
To make sure dasatinib is safe for you, tell your doctor if you have ever had:
Dasatinib may harm an unborn baby. You may need a pregnancy test to make sure you are not pregnant. Use effective birth control while using dasatinib and for at least 30 days after your last dose. Tell your doctor if you become pregnant.
Pregnancy may be less likely to occur while the mother or the father is using dasatinib. Both men and women should still use birth control to prevent pregnancy because the medicine can harm an unborn baby.
You should not breastfeed while taking dasatinib and for at least 2 weeks after your last dose.
Relate drugs
How to use Dasatinib
Usual Adult Dose of Dasatinib for Leukemia:
Chronic Phase CML: 100 mg orally once a day Accelerated Phase CML, Myeloid or Lymphoid Blast Phase CML, Ph+ ALL: 140 mg orally once a day Comments: -Treatment should be continued until disease progression or unacceptable toxicity. -The effect of discontinuing therapy after complete cytogenetic response is achieved has not been investigated. Uses: -For the treatment of adults with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase -For the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including Imatinib -For the treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy
Usual Pediatric Dose of Dasatinib for Leukemia:
Body weight of 10 kg to less than 20 kg: 40 mg orally once a day Body weight of 20 kg to less than 30 kg: 60 mg orally once a day Body weight of 30 kg to less than 45 kg: 70 mg orally once a day Body weight of at least 45 kg: 100 mg orally once a day Comments: -The recommended starting dosage is based on body weight. -The dose should be recalculated every 3 months or more often based on body weight changes. -Patients with Ph+ ALL, start therapy on or before day 15 of induction chemotherapy, when diagnosis is cOnfirmed and continue for 2 years. -Tablet dosing is not recommended for patients weighing less than 10 kg. Uses: -For the treatment of Ph+ CML in chronic phase -For the treatment of newly diagnosed Ph+ ALL in combination with chemotherapy
Warnings
Dasatinib is a cancer medication that slows the growth and spread of cancer cells in the body.
Dasatinib can lower blood cells that help your body fight infections and help your blood to clot. You may get an infection or bleed more easily. Call your doctor if you have unusual bruising or bleeding, or signs of infection (fever, chills, body aches).
Some people using dasatinib have developed a rare but serious condition called pulmonary arterial hypertension (PAH). PAH may be irreversible if not promptly treated, and this condition can be fatal. Talk to your doctor about your specific risk of developing PAH.
What other drugs will affect Dasatinib
Sometimes it is not safe to use certain medications at the SAMe time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.
Dasatinib may increase your risk of severe or fatal bleeding, especially if you also use a blood thinner or any medication to prevent blood clots.
Many drugs can interact with dasatinib, and some drugs should not be used at the same time. Tell your doctor about all your current medicines and any medicine you start or stop using. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions